From groundbreaking immunotherapies to advanced targeted treatments, oncology is set to make historic strides in the year ahead.

Gilead Sciences, Inc. ("Gilead") (b) Owner or controller of interests and short positions disclosed, if different from 1(a): The naming of nominee or v ...